Cardiovascular disease is the leading cause of death in men and women older than 65
years; therefore, its prevention is an important public health priority. Although cardiovascular …

Background: There is limited evidence on statin risk and effectiveness for patients aged 80+.
We estimated risk of recurrent myocardial infarction, muscle-related and other adverse …

In patients aged≥ 80 years without previous coronary artery disease, peripheral vascular
disease, or cerebrovascular disease, no evidence has shown a benefit from statin therapy …

Background Current statin use and symptoms among older adults in routine community
practice have not been well characterized since the release of the 2013 American College of …

Purpose This study aimed to evaluate the cost-effectiveness of statins for primary prevention
of stroke and myocardial infarction (MI) in the elderly in Singapore. Methods A Markov model …

A perceived lack of evidence for benefit and safety concerns may lead to underprescription
of HMG-CoA reductase inhibitors (statins) in older adults. This article reviews clinical data …

Primary prevention of cardiovascular events in older adults is challenging because of a
general paucity of evidence for safe and efficacious therapy. Furthermore, there is no …

There is a lack of evidence surrounding the efficacy of statins in the oldest old (≥ 80 years of
age). As such, there is controversy surrounding use of statins in this population. We sought …

BACKGROUND: Statins are the evidence-based drugs of choice for the prevention of
cardiovascular disease (CVD). OBJECTIVE: Statin use has increased in those≥ 65 years …

Importance Hypercholesterolemia is common among people older than 80 years.
Substantial functional heterogeneity exists among older patients, and decision making for …